Revvity

Pfizer and Blackstone Life Sciences Strike USD 1.5 Billion Co‑Funding Deal for Berobenatide – Potential First‑in‑Class Monthly GLP‑1 for Obesity
Others

Pfizer and Blackstone Life Sciences Strike USD 1.5 Billion Co‑Funding Deal for Berobenatide – Potential First‑in‑Class Monthly GLP‑1 for Obesity

Pfizer Inc. (NYSE: PFE) and Blackstone Life Sciences ("Blackstone") announced a strategic co‑funding agreement under which funds managed by Blackstone will pay up to a total of USD 1.5 billion…

Revvity and BioMap Sign Strategic AI4S Partnership – A "Dry‑Wet" Closed‑Loop Alliance to Accelerate AI‑Empowered Life Sciences

Revvity and BioMap Sign Strategic AI4S Partnership – A “Dry‑Wet” Closed‑Loop Alliance to Accelerate AI‑Empowered Life Sciences

Lepu Medical's Minwei Biotech Secures NMPA Clinical Trial Approval for MWX205 – World's First PCSK9/ANGPTL3 Dual‑Target siRNA for Dyslipidemia

Lepu Medical’s Minwei Biotech Secures NMPA Clinical Trial Approval for MWX205 – World’s First PCSK9/ANGPTL3 Dual‑Target siRNA for Dyslipidemia

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Sino Biopharmaceutical's CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D
CompanyDeals

Sino Biopharmaceutical’s CTTQ Partners with Revvity to Launch X‑Lab Joint Shared Laboratory for Antibody Drug R&D

CompanyDeals

Revvity and Sanyou Biopharmaceuticals Deepen Partnership to Advance Biologic Drug Development